Cyclacel pharmaceuticals reports first quarter financial results and provides business update

Kuala lumpur, malaysia, may 15, 2025 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines, today announced its first quarter financial results and provided a business update.
CYCC Ratings Summary
CYCC Quant Ranking